[Biological age in orthopedics : Importance, assessment, and clinical recommendations].
Key claim: In orthopedics, biological age should be treated as a multidimensional risk profile—frailty, sarcopenia, and functional measures predict outcomes beyond chronological age, while molecular aging clocks are not recommended for routine care.
Abstract
BACKGROUND: Chronological age insufficiently reflects differences in physiological reserve, resilience, and regenerative capacity. Biological age (BA) estimates aging from molecular, physiological, and functional characteristics. OBJECTIVES: To describe BA concepts and assessment methods and evaluate their relevance for orthopedic rehabilitation. MATERIALS AND METHODS: Narrative review based on structured MEDLINE/PubMed and manual search, with a focus on reviews, meta-analyses, consensus papers, and key methodological studies. RESULTS: Epigenetic, phenotypic, and laboratory-based models capture different dimensions of aging and are not directly comparable. Frailty, sarcopenia, gait speed, chair-rise performance, grip strength, endurance, and deficit accumulation have the greatest practical value. Frailty and sarcopenia predict complications, prolonged care, non-home discharge, and mortality after orthopedic procedures beyond chronological age. CONCLUSIONS: BA should be interpreted as a multidimensional risk profile. A staged assessment combining frailty screening, muscle strength, mobility, endurance, nutrition, and cognition is recommended. Molecular aging clocks are not currently recommended for routine care.
Why this matters
In orthopedics, biological age should be treated as a multidimensional risk profile—frailty, sarcopenia, and functional measures predict outcomes beyond chronological age, while molecular aging clocks are not recommended for routine care.